Trademark Overview
On Friday, December 6, 2024, a trademark application was filed for PROJECT ACT with the United States Patent and Trademark Office. The USPTO has given the PROJECT ACT trademark a serial number of 98889788. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, December 6, 2024. This trademark is owned by Breakthrough T1D. The PROJECT ACT trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Charitable fundraising services for promoting research and education relating to type 1 diabetes; Accepting and administering monetary charitable contributions to fund medical research; Financial services, namely, funding research in the field of type 1 diabetes
Promoting public awareness of type 1 diabetes, type 1 diabetes research, and treatments, preventions and cures for type 1 diabetes, by means of public advocacy
Providing information in the field of prevention, screening, diagnosis and treatment of type 1 diabetes; providing information in the field of prevention, screening, diagnosis and treatment of type 1 diabetes via a website; providing health information; providing health information in the field of type 1 diabetes; Medical information services, namely, developing guidelines for clinical trial models, recruitment, and endpoints
Providing information about medical research; providing information about medical research in the field of type 1 diabetes; Providing information about medical and scientific research via a website; Providing medical and scientific research information in the field of clinical trials
